TINA.org Action Sheds Light on SunPowerLED’s False Endorsement Claims
Letters alert agencies and organizations to company’s improper marketing.
NP Thyroid
Case Name (Date)
Faulkner et al. v. Acella Pharmaceuticals, LLC
22-cv-92, N.D. Ga.
(May 2022)
Product/Service
NP Thyroid
Allegations
Falsely marketing that medications contain a specific amount of the active ingredient when certain batches were recalled for containing too much or too little of the active ingredient
Falsely marketing medications as safe when certain batches were recalled because the amount of the active ingredient could cause serious adverse health consequences or death
Falsely marketing that medications are “[m]ade with the highest quality standards” and comply with applicable USP standards
Status
Settled
(Final approval granted)
The Latest
VIN History USA’s ‘Free’ VIN Report
TINA.org discovers some roadblocks to unlocking this purportedly free offer.
Amica Insurance: Back To Zero
Recent ad shows what it takes to make a comeback.
Will the MLM Industry Fix Its Earnings Claims Problem?
New research points to “no.”
TINA.org Supports Citizen Petition Calling for AI Pricing Transparency
Why disclosures are key to protecting informed consumer choice and competition.